Opinion

Video

Overcoming Barriers to Better Patient Outcomes in PAH

Ronald Oudiz, MD, FACP, FACC, FCCP, discusses the challenges and limitations associated with the adoption of new treatments and the impact of emerging therapies on patient outcomes, quality of life, and disease management in the long term.

Video content above is prompted by the following questions:

  • What are the potential challenges or limitations associated with the adoption of new treatments, such as cost, access, or safety concerns?
  • How might the evolving treatment landscape for PAH impact patient outcomes, quality of life, and disease management in the long term?
Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
Justin Oldham, MD, MS, an expert on IPF
Justin Oldham, MD, MS, an expert on IPF
Justin Oldham, MD, MS, an expert on IPF
Justin Oldham, MD, MS, an expert on IPF
Justin Oldham, MD, MS, an expert on IPF
Susan Perlman, MD, an expert on Friedreich's ataxia
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo